Should I Stay or Should I Go?:A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys

Autor: Victoria Rice Carlisle, Olivia M. Maynard, Darren Bagnall, Matthew Hickman, Jon Shorrock, Kyla Thomas, Joanna Kesten

Publikováno v: Carlisle, V, Maynard, O M, Bagnall, D, Hickman, M, Shorrock, J, Thomas, K H & Kesten, J 2023, ' Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys ', International Journal of Environmental Research and Public Health, vol. 20, no. 2, 1526 . https://doi.org/10.3390/ijerph20021526
International Journal of Environmental Research and Public Health; Volume 20; Issue 2; Pages: 1526

(1) The harm-reduction benefits of opioid agonist treatment (OAT) are well-established; however, the UK government’s emphasis on “recovery” may be contributing to a high proportion of people leaving treatment and low retention rates. We wanted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1c84c990c78288c94395abf6679068
https://hdl.handle.net/1983/302a8f6e-517f-48ed-bdb9-995334a6222c

Impact of Anticoagulant and Antiplatelet Use on Outcomes in Blunt Chest Injury

Autor: Ashley Dibbert, Victoria Rice, Megan Nguyen, Sara Roy, Pascal Udekwu, Anquonette Stiles

Publikováno v: The American surgeon. 85(8)

The aim of this study was to evaluate the impact of prehospital antiplatelet and/or anticoagulant (APAC) use on treatment and outcomes in patients with severe blunt chest injury. Patients with three or more rib fractures and a hospital length of stay

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf40528fa739035a67e5d108ff48110
https://pubmed.ncbi.nlm.nih.gov/31560306